Kato, H, Koike, S, Yokoyama, T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63: 175–179.
Newburger, JW, Takahashi, M, Burns, JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341–347.10.1056/NEJM198608073150601
Newburger, JW, Takahashi, M, Beiser, AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633–1639.10.1056/NEJM199106063242305
Nakamura, Y, Yashiro, M, Uehara, R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 2012; 22(3): 216–221.10.2188/jea.JE20110126
Maddox, RA, Holman, RC, Uehara, R, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int 2015; 57: 1116–1120.10.1111/ped.12733
McCrindle, BW, Rowley, AH, Newburger, JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation 2017; 135: e927–e999.
Yanagawa, H, Nakamura, Y, Yashiro, M, Hirose, K. Result of 12 nationwide survey of Kawasaki disease. In: Kato, H (ed). Kawasaki Disease, Elsevier Science, Amsterdam, 1995. pp. 3–14.
Yanagawa, H, Nakamura, Y, Yashiro, M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998; 102: 65.
Hirata, S, Nakamura, Y, Yanagawa, H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Pediatr 2001; 90:40–44.10.1111/j.1651-2227.2001.tb00253.x
Yang, HM, Du, ZD, Fu, PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr 2013; 172: 1641–7.
Akagi, T, Kato, H, Inouse, O, Sato, N, Imamura, K. Valvular heart disease in Kawasaki syndrome: incidence & natural history. Am Heart J 1990; 120: 366–372.